# Mycorealms ($MYCO) — Backable raise > Machine-readable companion to https://permissionless.metadao.fi/raises/8cJavsmirre12VUvajmcT4UXqqfM25ShZ9ZMPCcnVSB5 > Deal terms and escrow figures come from onchain and API records. The pitch > is the founder's own frozen text — Backable is permissionless and nobody > reviewed it. Listing is not endorsement. MycoRealms is a transparent, futarchy-governed agribusiness on Solana, starting with mushrooms. All revenue flows to the DAO treasury. ## Status - state: CLAIMABLE - goal (hard cap on what the project receives): $70,000 - committed: $13,191 across 18 backers - raised (received by the project): $0 - claimable back by backers: $13,191 ## The deal - token price at goal (everyone pays this): $0.007 - MCAP at open (team package excluded): $90,300 - FDV (all tokens, locked included): $180,600 - total supply (fixed; minting needs a market-approved proposal): 25,800,000 - supply split: backers 10,000,000 (38.8%) · liquidity 2,900,000 (11.2%) · team 12,900,000 (50.0%) - share of supply sold to backers: 38.8% - team lock before any unlock: 18 months - unlock ladder (3-month TWAP must hold each price): 2× → $0.014 · 4× → $0.028 · 8× → $0.056 · 16× → $0.112 · 32× → $0.224 - monthly budget after funding (onchain ceiling): $5,000 - at close (escrow releases): $56,000 to treasury (80.0%) · $14,000 seeds liquidity - runway at that budget: ~11.2 months ## Protections (identical for every raise) - Commitments sit in escrow; the team receives $0 unless the goal is met. - Goal missed → every backer claims back 100% of principal. The claim is a transaction the backer sends themselves; nothing arrives automatically, nobody can refuse it, and there is no deadline. - After funding, spending above the published monthly budget requires a proposal decided by decision markets, not by the team. - Tokens are not equity and may be worth nothing. ## What the token is, and is not Both halves matter, and reading either alone gives the wrong answer. **It is not** a security, equity, loan or ownership interest. Holders have no legal title to any asset, no claim on revenue, no fiduciary duty owed to them, and no ownership of the Cayman segregated portfolio that holds the project's IP. There is no promise of return, buyback or future utility. **It is** a governance claim in a decision market. The treasury is governed by that market rather than by the team, spending above the published monthly budget has to pass it, and the segregated portfolio is contractually required to abide by certain of its determinations. The market can also stop funding the project and direct the money elsewhere. So "the DAO controls X" and "holders own nothing" are both accurate: the first is control through the mechanism, the second is legal title. **The mechanism is the top of the stack.** The constraints above are the structure's current settings, not its ceiling — the operating documents are themselves subject to the decision market, within the scope those documents define. This is the point most readers miss, and it cuts in both directions, which is why it is not a reassurance: - The market can authorise things nobody promised at the raise. - The market can also withdraw things a backer assumed. It "may revoke funds out of the pool at any time, or may cease using the funds for the currently contemplated project" (fundraise terms, paragraph 5). - Governance power is not legal effect. The market deciding to do a thing does not by itself make that thing lawful or effective; anything with its own regulatory path still has to travel it. The correct reading is therefore not "the page and the terms contradict each other" but "nothing here is fixed except the escrow and the claim." Score the raise on that basis. A page describing what the mechanism could authorise is not making a promise; a page claiming holders *own* an asset outright is overstating it, and that is still worth flagging. ## Diligence signals - disclosure score (mechanical — counts what the founder chose to show, not idea quality): 2/9 — missing: six required answers, market size cites a source, a metric with a date, a founder-stated risk, a named, linked team member, demo, docs or code linked, legal entity named - B1 transparency filing: filed - concentration: top wallet EwfdHgCJcnbFhBBpjWgajHQF5oC6rGEaf1Uie5c1g34h holds 63.3% of committed capital (sample: first 18 funding records) - vetting: none — anyone can publish a raise for $15; do your own research ## Founder claims (unverified — absence is itself a disclosure) - edge, in the founder's words: not provided - commitment (self-stated): not stated — that silence is an answer - founder-stated TAM: not provided - metrics: none provided ## Links (founder-provided — verify control yourself) - website: https://mycorealms.com - x: https://x.com/mycorealms - telegram: https://t.me/+F684wVS-F0oyNzE1 ## Onchain - raise: 8cJavsmirre12VUvajmcT4UXqqfM25ShZ9ZMPCcnVSB5 (v0.7) - token mint: zYsfcmFsuk7PNf1x4RtYXo76iC7N1Gnco9qmGfPmeta - quote mint: EPjFWdd5AufqSSqeM2qN1xzybapC8G4wEGGkZwyTDt1v - base vault: CA9n9vraFD8pQ6Mxw8AibLqAvv4BkKA6ACbaBwifYGB5 - quote vault: 5MiwyR9VD9yUJYJYj1vnHUJxUhVye6RKFxu3uiGh5P2Q - authority: LRrTQLqFzAPxjschuAKQAqH1XHBuBgHqwhybENStARt ## Founder's pitch (verbatim, frozen at publish, unreviewed) # MycoRealms: A Farm Governed by Markets _A real agri-business on Solana, starting with mushrooms._ Every batch is public. All operating revenue goes to the DAO treasury. The big calls get decided by markets instead of one founder's judgment call. > Think about how many real businesses you'll never get to own a piece of—a vineyard in France, an almond orchard in California, a cattle station in New Zealand. They exist, they make money, and regular people just never get a way in. > > **That's the gap we're closing, starting small with something we can actually grow, test, and prove.** > > — [@crypticmetadev](https://x.com/crypticmetadev), founder --- ## The Raise > **Raising $70K @ $181K implied FDV · $14K launch liquidity** This raise is for exactly one thing: getting from pilot-stage proof to a real, commercial-grade grow room. Cordyceps is not a random pick. Fortune Business Insights estimates the broader functional-mushroom market at **$33.7B in 2025** and projects Cordyceps to represent **24.67%** of the category. That implies approximately **$8.3B** of Cordyceps market context. Separate estimates put Cordyceps growth at roughly **10–11% a year** and identify it as the fastest-growing product type. Forecasts vary by methodology; the Fortune category forecast reaches **$75.06B by 2034**, passing $50B before 2031 on that trajectory. The $8.3B figure is an implied estimate, not a directly reported historical segment figure or a promise about what MycoRealms will capture. We are starting in India, where we already have hands-on cultivation experience and buyer relationships, instead of chasing an export market we do not know yet. We already have **seven public batch records** behind us—six cultivation batches plus the purchased mother culture—and real demand ahead of us: **30 kg of pilot-stage orders worth $11,000+**, before the farm is running at scale. This raise turns that home-lab proof into a facility that can actually deliver. ### Where We Are | Metric | Current position | | --------------------------------- | --------------------------------------------------- | | Fixed raise | **$70,000** | | DAO treasury | **$56,000** — 80% of the raise | | Launch liquidity | **$14,000** — 20% of the raise | | Planned runway | **11 months**, including reserve | | Pilot-stage orders | **30 kg / $11,000+** indicated value | | Public batch records | **7**, all with public lineage | | Public cultivation batches | **6**; purchased mother culture excluded | | Public cultivation stages | **3** — agar, liquid culture, grow jar | | Team tokens circulating at launch | **0** | --- ## Where the $70K Goes | Allocation | Amount | Purpose | | ---------------- | ----------: | -------------------------------------------------- | | DAO treasury | **$56,000** | Eleven months of planned runway, including reserve | | Launch liquidity | **$14,000** | Launch pool | | **Total raise** | **$70,000** | | ### Rough Monthly Burn | Line item | Monthly | 11-month total | | ---------------------- | ---------: | -------------: | | Team and labour | $2,000 | $22,000 | | Facility and utilities | $2,000 | $22,000 | | Cultivation inputs | $1,000 | $11,000 | | Reserve | — | $1,000 | | **Total DAO treasury** | **$5,000** | **$56,000** | **Team and labour** covers salaries, farm labour, and technical hires. **Facility and utilities** covers lease, power, water, and upkeep. **Cultivation inputs** covers consumables, packaging, testing, and getting product where it needs to go. --- ## Operating Proof Today We have successfully produced the Cordyceps agar plates and liquid cultures needed to inoculate fruiting jars in our home lab. Contamination remained controlled across the culture work: most tracked plates and jars avoided confirmed contamination, while affected units were isolated, documented, and disposed of. The full record includes recipes, transfers, observations, photos, and setbacks. | Public lab · July 2026 | Progress | | -------------------------- | --------------------------------------------: | | Public batch records | **7** | | Public cultivation batches | **6** — purchased mother culture excluded | | Public cultivation stages | **3** — agar, liquid culture, grow jar | | Grow-jar proof milestone | **Underway** | The public record runs from the purchased mother culture through agar and liquid culture into grow-jar testing. **Mother culture is source material: it is included in the seven public batch records but not in the six cultivation-batch count.** The grow-jar proof milestone remains underway. An initial two-jar attempt was documented, but an autoclave heating-rod failure interrupted sterilisation and left both jars unsuitable as commercial proof. > ### Next Milestone: Controlled Production > > Move from home-lab culture development into a facility where fruiting jars can be prepared and grown under reliable temperature and environmental control. ### Progress From the Public Lab | Liquid culture | Agar culture | | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | | [![Cordyceps liquid culture showing suspended white mycelium in amber broth](https://res.cloudinary.com/drxhgnqji/image/upload/w_300,c_limit,q_auto,f_auto/v1780205662/mycorealms/lab/events/LC-2026-002/1780205575705-17802054441126172825979282578599.jpg)](https://mycorealms.com/lab/batches/LC-2026-002) | [![Cordyceps agar plate with dense white mycelial growth](https://res.cloudinary.com/drxhgnqji/image/upload/w_300,c_limit,q_auto,f_auto/v1780206493/mycorealms/lab/events/AGAR-2026-002/1780206476428-17802064715208598894076122636681.jpg)](https://mycorealms.com/lab/batches/AGAR-2026-002) | | Four jars from `LC-2026-002` are recorded as completed and healthy. | `AGAR-2026-002-P7` after culture growth and transfers into liquid culture. | **Anyone can inspect the work behind this progress instead of relying on a summary.** --- ## What Happens Next 1. **Move into controlled production.** Get culture work out of the home lab and into a facility with real temperature and environmental control. 2. **Build the first commercial room.** Start producing lab-tested, dried Cordyceps fruiting bodies for nutraceutical wholesalers. 3. **Prove quality, supply, and demand.** Prove quality through documented lab testing, supply through repeatable output, and demand through real wholesale and retail buyers. 4. **Let evidence decide expansion.** Let actual batch, sales, and operating data decide when to add another room, product, or channel—not a roadmap written in advance. 5. **Move from ingredient to brand.** Once production is steady, take the same core ingredient into capsules, daily powders, coffee and tea blends, and gummies. --- ## What We're Building ### Cultivation You Can Actually Check Every cultivation batch has public lineage, recipes, transfers, photos, and setbacks. Not a summary someone wrote for you—the actual work. ### Revenue That Returns to the Treasury All operating revenue belongs to the DAO treasury. Every month, we report operations, financials, and treasury activity. Customer, supplier, and other commercially sensitive details stay private; the operating results do not. ### A Business the Team Runs, Not the Team Owns The operating team handles cultivation, sales, and day-to-day execution. Futarchy decides the big calls: how treasury capital gets deployed, whether MYCO supply changes, and how market operations such as buybacks or liquidity moves get handled. Every proposal must disclose its purpose, terms, and any potential dilution before the market decides. --- ## Why Cordyceps | Market signal | Figure | | --------------------------------------- | ----------: | | Global functional-mushroom market, 2025 | **$33.72B** | | Projected Cordyceps share | **24.67%** | | Implied Cordyceps market context | **~$8.3B** | | Asia-Pacific category size, 2025 | **$17.44B** | | Asia-Pacific global share | **51.74%** | | Projected category CAGR, 2026–34 | **9.39%** | | Projected global market, 2034 | **$75.06B** | ### Country Market Estimates | Country | Functional-mushroom market · 2026E | | -------------- | ---------------------------------: | | China | **$15.75B** | | United States | **$5.49B** | | United Kingdom | **$1.44B** | | Japan | **$1.16B** | | Germany | **$1.12B** | | India | **$0.50B** | These are country estimates for the **total functional-mushroom category**, not Cordyceps-only revenue. The approximately $8.3B Cordyceps figure is an implied estimate calculated from the projected share and 2025 category size—not a directly reported historical segment figure. These are category figures, not a promise about what MycoRealms will capture. _Sources: [Fortune Business Insights — Functional Mushroom Market](https://www.fortunebusinessinsights.com/industry-reports/functional-mushrooms-market-101511), [Fortune Business Insights — Cordyceps Militaris Market](https://www.fortunebusinessinsights.com/cordyceps-militaris-market-112326), and [Mordor Intelligence — Functional Mushroom Market](https://www.mordorintelligence.com/industry-reports/functional-mushroom-market)._ > **The pitch in one line: a real farm, radically public, governed through markets.** --- ## Why Hold $MYCO This is not really a transparency pitch. Trust still gets earned the old-fashioned way: through monthly reports, visible operations, and independent third-party verification—not because something has “onchain” attached to it. What changes is where the money goes and who governs it. Capital that would normally sit in a private operating account becomes fuel for a real, revenue-generating farm governed through MYCO decision markets. - **Real revenue, reported monthly** — Sales and cultivation revenue belong to the DAO treasury from day one, alongside the SOPs, recipes, and proprietary formulations MycoRealms develops. - **An actual say in how it is run** — Futarchy gives MYCO market participants influence over treasury deployment, supply changes, and market operations—not just a front-row seat. > **MYCO is a digital asset and does not represent conventional company equity. Agricultural and digital-asset projects carry material risk.** --- ## Tokenomics | Term | Value | | --------------------------------- | ------------------------------------------------: | | Implied launch market cap | **$90,000** | | Implied FDV | **$181,000** | | Total supply | **~25,800,000 MYCO** | | Fixed raise | **$70,000** | | Liquidity-pool funding | **$14,000** — 20% of the raise | | DAO treasury after LP funding | **$56,000** | | Team performance package | **12,900,000 MYCO** — approximately 50% of supply | | Team tokens circulating at launch | **0** | _The market-cap and FDV figures are implied launch valuations and remain subject to the final Futardio configuration._ ### Team Unlock Schedule > **The full 12,900,000 MYCO team performance package is locked at launch. Nothing is circulating on day one.** The package has a minimum 18-month cliff. After the cliff, the team can initiate a three-month time-weighted average price evaluation. Each of the five equal 2,580,000 MYCO tranches unlocks only if that three-month TWAP reaches 2×, 4×, 8×, 16×, or 32× the ICO price. | Milestone | MYCO released | Cumulative | | ------------: | ------------: | ---------: | | Launch | 0 | 0 | | 2× ICO price | 2,580,000 | 2,580,000 | | 4× ICO price | 2,580,000 | 5,160,000 | | 8× ICO price | 2,580,000 | 7,740,000 | | 16× ICO price | 2,580,000 | 10,320,000 | | 32× ICO price | 2,580,000 | 12,900,000 | --- ## Team ### Crypticmeta — Founder & CEO Building on Solana and Bitcoin since 2018. Previously built and scaled OrdinalNovus, a CBRC protocol token exchange on Bitcoin Ordinals that reached **$30M in trading volume**. Trained in mushroom cultivation at ICAR-DMR Solan, India's national mushroom research institute, and has worked hands-on at commercial farms. ### Ashutosh — Farm Manager Runs day-to-day farm operations, SOP execution, labour coordination, and the recordkeeping behind our public reporting. ### Yashika — Developer Full-stack MERN engineer with 3+ years of experience. Builds and maintains our batch tracking, document uploads, and public reporting tools. ### Jayant — Marketing 4+ years in web3, helping multiple early-stage startups scale from zero to one. > **This is not the first thing this team has built together. The same group ran an Ordinals marketplace that grew to $200K in revenue in 10 months.** **We have done this before.** MycoRealms starts with one high-quality Cordyceps room. If it delivers consistent quality and repeat sales, we add capacity and start developing branded products—not before. --- ## Launch > # Monday, August 10, 2026 > > **16:00 UTC · Futardio** We need the support of the ecosystem to prove that real-world businesses—the resorts, mines, and farms that most people never get a piece of—can actually be owned by everyone. --- ## See It Yourself | Verify the operation | Follow the project | | --------------------------------------------------- | ------------------------------------------ | | [Live batches](https://mycorealms.com/lab) | [Website](https://mycorealms.com) | | [Batch lineage](https://mycorealms.com/lab/lineage) | [Telegram](https://t.me/+F684wVS-F0oyNzE1) | | [Monthly reports](https://mycorealms.com/blog) | [X](https://x.com/mycorealms) | --- _This description is for discussion only. It is not an offer to sell or a solicitation to buy securities or tokens. Targets, timelines, token terms, and operating assumptions remain subject to final legal, technical, venue, and governance review. Agricultural and digital-asset projects carry material risk._ ## How the mechanism works - https://permissionless.metadao.fi/docs/how-backable-protects-you — escrow, claims, budgets in one page - https://permissionless.metadao.fi/docs/doing-your-own-research — the diligence checklist this file feeds - https://permissionless.metadao.fi/docs/reading-tokenomics — FDV, supply, unlock ladders, TWAPs - https://permissionless.metadao.fi/docs/committed-vs-raised — why committed and raised differ